Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023
-
Understanding Dual Eligibility: A Guide for People with HIV About Medicare and Medicaid Coverage
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
-
Integration of Buprenorphine into HIV Primary Care Settings: Curriculum
The purpose of this curriculum is to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
It provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.
Resource updated 03/12/2024
-
Integration of Buprenorphine into HIV Primary Care Settings: Training Manual
Overview of training manual on integrating buprenorphine treatment into HIV primary care.
Curriculum updated on 08/01/2012 -
Integration of Buprenorphine into HIV Primary Care Settings: Curriculum
Curriculum updated on 08/01/2012 -
Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Curriculum updated on 09/05/2012 -
Ten Years of Health Coverage Help: ACE TA Center
A decade of impact: The ACE TA Center's milestones and what’s new.News Article updated on 04/11/2024 -
Webinars on Demand: Medicare and Medicare-Medicaid Dual Eligibility for RWHAP Clients
ACE TA Center webinars covering Medicare and Medicare-Medicaid dual eligibility for RWHAP clients.News Article updated on 04/15/2024 -
RWHAP Part C, Part D, & Part F Dental Programs Stakeholder Meeting - April 2024
HAB updates, infant feeding for individuals with HIV in the US, and Building Collaborative Partnerships.Resource updated 04/22/2024
-
Medicaid Unwinding Updates
-
RWHAP Part C Early Intervention Services Program: Existing Geographic Service Areas (HRSA-25-002, HRSA-25-003, HRSA-25-004)
HRSA HIV/AIDS Bureau technical assistance webinar for the Notice of Funding Opportunity (NOFO): FY2025 Ryan White HIV/AIDS Program Part C Early Intervention Services (EIS) Program: Existing Geographic Areas, HRSA-25-002, HRSA-25-003, HRSA-25-004.Resource updated 05/24/2024
-
Over 50,000 Health Professionals Trained: AETC 2022 Report
In 2021-2022, 56,383 health professionals received training in HIV clinical topics, provided by the HIV clinical training network under HRSA's Ryan White HIV/AIDS Program.News Article updated on 05/06/2024 -
Patient-Centered Appointment Reminders
Allegheny Health Network implemented Patient-Centered Appointment Reminders over a five-month period to improve engagement in care for people with HIV. This intervention included text message reminders, a process for identifying and addressing barriers to care, home visits, and outreach to patients after missed appointments. Compared to the pre-intervention cohort, the post-intervention group showed a significant decrease in clinic no-show rates.Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
-
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
HAB You Heard - June 2024
Monthly HRSA HIVAIDS Bureau webinar open to all RWHAP recipients, subrecipients, stakeholders, and federal staff. Pre-registration required.Event updated 06/06/2024
-
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
-
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023